Article
Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
Pathology, research and practice - 1 Sept 2014
Berger Franziska, Geddert Helene, Faller Gerhard, Werner Martin, Dimmler Arno
Abstract excerpt
PURPOSE: Increasing evidence indicates that TGFbeta- and EGFR-signaling is involved in the pathogenesis of keratoacanthoma (KA) and squamous cell carcinoma (SCC) of the skin. We analyzed the expression pattern of TGFbeta-signaling components and screened for mutations in tgfbetaR1, egfr, kras and braf in KAs and SCCs. METHODS: Immunohistochemical analysis of TGFbeta1, TGFbetaR1, TGFbetaR2 and phospho-SMAD2/3 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
